RxSight, Inc.
RXST- Exchange
- Nasdaq
- Industry
- Ophthalmic Goods
- SEC CIK
- 0001111485
In the last 90 days, RxSight, Inc. insiders filed 0 open-market purchases and 4 sales; 151 institutions reported holding it in 13F filings for Q2 2026, worth $199.8M in total; no superinvestor holds it.
Q2 2023 vs. Q1 2023
How the institutions holding RxSight, Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 74 | 115 | +41 |
| Shares | 15.9M | 22.1M | +6.27M (+39.5%) |
| Value | $264.4M | $637.0M | +$372.6M (+140.9%) |
New holders (48)
Institutions that held RxSight, Inc. at the end of Q2 2023 but not at the end of Q1 2023.
Sold out (7)
Institutions that held RxSight, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| OrbiMed Advisors LLC | 1,202,833 | $20.1M |
| Belpointe Asset Management LLC | 105,250 | $1.76M |
| Bridger Management, LLC | 99,100 | $1.65M |
| Magnetar Financial LLC | 88,236 | $1.47M |
| Soleus Capital Management, L.P. | 80,000 | $1.33M |
| XTX Topco Ltd | 16,763 | $279.6K |
| Boothbay Fund Management, LLC | 16,108 | $268.7K |